Cobimetinib is approved for treatment of?
Correct Answer: Melanoma
Description: Cobimetinib is approved for RX of melanoma in patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation, in conjunction with Vemurafenib. Cobimetinib - Reversible inhibitor of mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase.
Category:
Dental
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now